Cargando…
CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer
BACKGROUND: Lung cancer (LC) is the leading type of cancer worldwide, yet it’s challenging to detect early LC. Therefore, it is valuable to explore diagnostic biomarker that can distinguish malignant pulmonary lesions from benign diseases. The potential role of plate factor-4 variant (CXCL4L1) will...
Autores principales: | Zhang, Lei, Li, Guangping, Zhang, Hongxin, Liu, Huaqun, Li, Songlin, Wang, Yanan, Qi, Huisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188318/ https://www.ncbi.nlm.nih.gov/pubmed/35698601 http://dx.doi.org/10.2147/CMAR.S352217 |
Ejemplares similares
-
Serum Markers CA125, CA153, and CEA along with Inflammatory Cytokines in the Early Detection of Lung Cancer in High-Risk Populations
por: Li, Guangping, et al.
Publicado: (2022) -
Calcified or ossified benign soft tissue lesions that may simulate malignancy
por: Kwee, Robert M., et al.
Publicado: (2019) -
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions
por: Fei, Xiang, et al.
Publicado: (2022) -
Vascular index measured by smart 3-D superb microvascular imaging can help to differentiate malignant and benign breast lesion
por: Zhang, Xiao-Yan, et al.
Publicado: (2019) -
Pulmonary Multiple Nodules: Benign or Malignant?
por: Liu, Jing, et al.
Publicado: (2018)